Skip to main content
Institutional Filer · CIK 1801265

Madison Avenue Partners, LP


PERIOD 2026-Q2 (filed 2026-08-14) · SOURCE: SEC EDGAR (PUBLIC)

Holdings as of the 2026-Q2 13F-HR filing (filed 2026-08-14). 13F is disclosed up to 45 days after quarter-end.

25
Reported positionstop 5 = 50% of reported value
$2.3B
Reported valueas of 2026-Q2 13F-HR
+1.0%
Reported value QoQincrease from 2026-Q1
25
Quarters on file2019-Q4 to 2026-Q2

What a 13F does — and does not — show

These figures come from Form 13F, a quarterly filing that large US institutional managers must submit to the SEC. It is a useful window, but a partial and lagged one, so read it carefully:

  • It is a snapshot, up to 45 days old. A 13F shows what a manager held on the last day of a quarter, filed up to 45 days later — the fund may have traded since.
  • Long US-listed stocks only. It excludes short positions, cash, bonds, most derivatives, and non-US or private holdings, so it is not the fund’s whole portfolio.
  • Reported 13F value is not assets under management. Every share and concentration figure below is a percentage of the reported 13F value only — not the firm’s total assets.
  • It describes, it does not recommend. A large or long-held position is not an endorsement, and none of this is investment advice.

Concentration

Share of reported portfolio value. Long US-listed equity positions as filed; percentages are of reported 13F value, which excludes shorts, cash, non-US and private holdings.

TierReported valueShare
Top position$281M12.1%
Top 5$1.2B49.9%
Top 10$1.8B77.1%

Top holdings

#SecuritySharesReported value% of value
1GHM GRAHAM HLDGS CO added246,368$281M12.1%
2INVH INVITATION HOMES INC new8,335,309$252M10.8%
3MKL MARKEL GROUP INC added112,325$219M9.4%
4CPNG COUPANG INC added12,457,195$216M9.3%
5MICC MAGNUM ICE CREAM CO NV added10,892,592$190M8.2%
6TBPH THERAVANCE BIOPHARMA INC added9,212,252$157M6.7%
7SOLV SOLVENTUM CORP added1,741,221$134M5.8%
8STAA STAAR SURGICAL CO added4,175,748$120M5.2%
9INDV INDIVIOR PLC trimmed2,874,368$118M5.1%
10LKFT LAKEFRONT BIOTHERAPEUTICS NV added3,447,807$103M4.4%
11GMED GLOBUS MED INC added935,216$74M3.2%
12OCTV OCTAVE INTELLIGENCE PLC new4,222,663$69M3.0%

Sector mix

Reported 13F value by sector, as a share of the largest positions we rank. Sectors come from company reference data joined to each holding. 22% of this value is not classified to a sector and is excluded from the mix. Long US-listed equity positions as filed.

SectorReported valueShare
Healthcare$603M25.9%
Industrials$327M14.1%
Real Estate$252M10.8%
Financial Services$219M9.4%
Consumer Cyclical$216M9.3%
Consumer Defensive$85M3.7%
Technology$70M3.0%
Communication Services$40M1.7%

How this filer invests

Reproducible measures computed from the positions in this filer’s own 13F filings — not from any outside estimate.

How concentrated the book is

77%
Top 10 positions (of reported 13F value)
12%
Largest position
0.07
Concentration index (HHI, 0–1) — broadly diversified

Across 25 reported positions. Shares are of reported 13F value (long US-listed equity), which is not the firm’s total assets. The concentration index (HHI) is the sum of each position’s squared weight — higher means a book concentrated in fewer names.

How much the book turned over

7
New positions
9
Exited
7
Added to
8
Trimmed
59%
Turnover (new + exited vs prior count)

Between the 2026-Q1 and 2026-Q2 filings, on the stable identity of each holding (share classes combined). New positions and exits are counted by presence; adds and trims by share count, and a share-count change matching a standard split ratio with the value held steady is not counted as either.

Long-term holdings vs. higher turnover

Of its 20 largest reported positions, 9 have appeared in its 5 most recent consecutive quarterly filings (more than a year), and 11 are more recent. This filer holds a mix of longer-term and more recently established large positions.

Notable sizing changes among its long-held positions:

  • INDV — share count increased 25564%
  • SNDK — share count reduced 100%
  • LKFT — share count increased 84%
  • GMED — share count reduced 45%
  • TBPH — share count increased 31%
  • SOLV — share count reduced 29%

Directional only, measured over the filer’s largest reported positions across the quarters we track. 13F is a quarter-end snapshot, so a name can be held continuously yet slip in and out of the largest positions; this is a starting question, not a verdict.

Quarter-over-quarter changes — filed 2026-08-14

What changed between the 2026-Q1 and 2026-Q2 13F filings. New positions and exits reflect the tracked snapshot; adds and trims are measured on reported value (split-invariant), and moves under $0.25M are omitted as noise.

Between the 2026-Q1 and 2026-Q2 filings, this filer opened its largest new position in INVH, fully exited ICLR, added most to STAA, and trimmed SNDK the most. This describes what the 13F reported — not a recommendation.

New positions 7

  • INVH$252M
  • OCTV$69M
  • SANM$48M
  • PRIM$46M
  • AD$40M
  • MRP$9M

Exited 9

  • ICLR$142M
  • MOH$84M
  • WLY$26M
  • PRMB$25M
  • DNOW$16M
  • CBC$11M

Largest adds

  • STAA$74M
  • MKL$51M
  • CPNG$40M
  • LKFT$29M
  • GHM$21M
  • MICC$19M

Largest trims

  • SNDK$371M
  • AIVEUR$14M
  • INDV$14M
  • BTI$1M
  • TPB$482K

Portfolio trend

Reported 13F value and position count by filing quarter (independent scales).

Reported valuePosition count

Frequently asked

What does Madison Avenue Partners, LP own?

Madison Avenue Partners, LP reported 25 long US-listed equity positions worth $2.3B in its 2026-Q2 13F filing.

What changed in Madison Avenue Partners, LP's portfolio last quarter?

Madison Avenue Partners, LP's 2026-Q2 filing is compared against its prior 13F to identify new positions, exits, and the largest increases and reductions, measured on reported value.

Where does this data come from?

Holdings are parsed from SEC Form 13F-HR filings on EDGAR (public filings). 13F is disclosed up to 45 days after quarter-end and reflects long US-listed equity positions only. Informational, not investment advice.

About 13F filings

A Form 13F is a quarterly disclosure that institutional investment managers with over $100 million in US-listed equities must file with the SEC. In plain English: it is a snapshot of the long stock positions a fund held at the end of a quarter. It is filed up to 45 days after quarter-end, so it is backward-looking — the manager may have traded since — and it covers long US-listed equities only, not short positions, cash, or private holdings. Reading a 13F tells you what a manager owned, not whether you should own it.

Learn how to read a 13F

Explore other funds